Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
Clinical trial NCT01937117 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01937117
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-30
- Primary completion
- 2018-03-20
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.